SEC Form 4 · accession 0001127602-18-011882

UNITED THERAPEUTICS Corp · UTHR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Martine A Rothblatt

Officer — Chairman & CEO · Director

Period of report

Mar 15, 2018

Accepted (ET)

Mar 16, 2018 · 5:40 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001082554

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Mar 15, 2018	M	21,512	$52.65	A	21,652	D
Common Stock^F2	Mar 15, 2018	S	19,612	$110.8155	D	2,040	D
Common Stock^F3	Mar 15, 2018	S	1,800	$111.4116	D	240	D
Common Stock	Mar 15, 2018	S	100	$112.33	D	140	D
Common Stock	Mar 16, 2018	M	21,513	$52.65	A	21,653	D
Common Stock^F4	Mar 16, 2018	S	13,144	$111.0187	D	8,509	D
Common Stock^F5	Mar 16, 2018	S	8,369	$111.8713	D	140	D
Common Stock	holding	—	—		—	683,489	I	By Trusts

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Options	$52.65	Mar 15, 2018	M	21,512	D	Dec 31, 2009	Dec 31, 2019	Common Stock	21,512	344,196	D
Stock Options	$52.65	Mar 16, 2018	M	21,513	D	Dec 31, 2009	Dec 31, 2019	Common Stock	21,513	322,683	D

Explanation of responses

F1This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
F2This transaction was executed in multiple trades at prices ranging from $110.19 to $111.18. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3This transaction was executed in multiple trades at prices ranging from $111.19 to $111.83. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4This transaction was executed in multiple trades at prices ranging from $110.43 to $111.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5This transaction was executed in multiple trades at prices ranging from $111.44 to $112.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.